As of 30.01.2020
Name of the project: Transglutaminase-2 ferment as a target for therapy of hepatocellular carcinoma
Strategy for Scientific and Technological Development Priority Level: в
Research directions: Identifying molecular mechanisms of oncogenesis and search for new targets for anti-tumor therapy
Project objective: Studying the role of transglutaminase-2 (TG2) and heat shock factor (HSF1) in the process of development of hepatocellular carcinoma in cells of model animals as well as assessment of prospects of the TG2/HSF1 path as a potential target for innovative therapy of hepatocarcinoma.
Hosting organization
|
Field of studies
|
City
|
Invited researcher
|
Time span of the project
|
---|---|---|---|---|
Research Laboratory «Molecular Immunology»
Kazan (Volga region) Federal University |
Fundamental medicine |
Kazan |
Hans-Uwe Simon
Switzerland |
2021-2023 |
Laboratory of the Mosaic of Autoimmunity
Saint Petersburg State University |
Fundamental medicine |
St. Petersburg |
Shoenfeld Yehuda
Israel |
2017-2021 |
Laboratory of Arrythmologists
A. N. Bakulev National Medical Research Center for Cardiovascular Surgery |
Fundamental medicine |
Moscow |
Sergey Mikhailovich Danilov
USA |
2014-2018 |